Heart failure & cardiomyopathies

1. JACC Heart Fail9 Aug 2023

   Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HF

   Secondary analysis

2. JACC Heart Fail9 Aug 2023

   Interleukin-6 in Patients With Heart Failure and Preserved Ejection Fraction

   Secondary analysis

3. JACC Heart Fail9 Aug 2023

   Age, Sex, and Outcomes in Heart Failure With Reduced EF: Insights From the VICTORIA Trial

   Secondary analysis

4. Europace4 Aug 2023

   Effectiveness of adding a defibrillator with cardiac resynchronization therapy in heart failure according to the modified Model for End-stage Liver Disease-Albumin score

   Cohort study

5. Circulation3 Aug 2023

   Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial

   Randomised controlled trial

6. Eur J Heart Fail3 Aug 2023

   Culture, Ethnicity, and Socio-Economic Status as Determinants of the Management of Patients with Advanced Heart Failure who Need Palliative Care: A Clinical Consensus Statement from the Heart Failure Association (HFA) of the ESC, the ESC Patient Forum, and the European Association of Palliative Care

   Guideline or statement

7. Eur J Heart Fail3 Aug 2023

   Impact of Comorbidities on Health Status Measured Using the Kansas City Cardiomyopathy Questionnaire in Patients with Heart Failure with Reduced and Preserved Ejection Fraction

   Meta-analysis

8. Eur J Heart Fail3 Aug 2023

   Mineralocorticoid Receptor Antagonist Initiation During Admission is Associated with Improved Outcomes Irrespective of Ejection Fraction in Patients with Acute Heart Failure

   Secondary analysis

9. Eur J Prev Cardiol2 Aug 2023

   Impact of pregnancy on the natural history of women with hypertrophic cardiomyopathy

   Cohort study

10. JACC Heart Fail2 Aug 2023

    Geographic Variation in the Quality of Heart Failure Care Among U.S. Veterans

    Cohort study

11. JACC Heart Fail2 Aug 2023

    Serum Proteomic Analysis of Peripartum Cardiomyopathy Reveals Distinctive Dysregulation of Inflammatory and Cholesterol Metabolism Pathways

    Mechanistic study

12. JAMA1 Aug 2023

    Genetic Architecture of Dilated Cardiomyopathy in Individuals of African and European Ancestry

    Cross-sectional study

13. J Am Coll Cardiol1 Aug 2023

    C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease

    Cohort study

14. Eur J Prev Cardiol1 Aug 2023

    Echocardiographic heart ageing patterns predict cardiovascular and non-cardiovascular events and reflect biological age: the SardiNIA study

    Cohort study

15. J Am Coll Cardiol1 Aug 2023

    Global Comparison of Readmission Rates for Patients With Heart Failure

    Meta-analysis

16. Eur J Prev Cardiol31 Jul 2023

    Haemodynamic gain index and heart failure incidence- Prognostic and preventive value

    Cohort study

17. Eur J Heart Fail31 Jul 2023

    Prediction Models for Heart Failure in the Community: A Systematic Review and Meta-Analysis

    Meta-analysis

18. Eur J Heart Fail31 Jul 2023

    Remote Patient Management of Heart Failure Across the Ejection Fraction Spectrum: A Pre-Specified Analysis of the TIM-HF2 Trial

    Secondary analysis

19. Eur J Heart Fail26 Jul 2023

    Improved Long-Term Survival with Tafamidis Treatment in Patients with Transthyretin Amyloid Cardiomyopathy and Severe Heart Failure Symptoms

    Secondary analysis

20. Eur J Heart Fail26 Jul 2023

    Knowledge About Self-Efficacy and Outcomes in Patients with Heart Failure and Reduced Ejection Fraction

    Meta-analysis

21. JACC Heart Fail26 Jul 2023

    Use of Clinical and Echocardiographic Evaluation to Assess the Risk of Heart Failure

    Diagnostic or prognostic study

22. Circulation25 Jul 2023

    Detection of Left Ventricular Systolic Dysfunction From Electrocardiographic Images

    Diagnostic or prognostic study

23. Eur J Heart Fail24 Jul 2023

    Real-World Use of Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Heart Failure and Reduced Ejection Fraction: Data from the Swedish Heart Failure Registry

    Cohort study

24. JACC Cardiovasc Imaging19 Jul 2023

    Myocardial Strain Measurements Derived From MR Feature-Tracking: Influence of Sex, Age, Field Strength, and Vendor

    Meta-analysis

25. Circulation19 Jul 2023

    Left Ventricular Dysfunction Associated With Brain Death: Results From the Donor Heart Study

    Cohort study

26. Eur J Prev Cardiol18 Jul 2023

    Arterial hypertension in patients with takotsubo syndrome: prevalence, long-term outcome, and secondary preventive strategies: a report from the Takotsubo Italian Network register

    Cohort study

27. Circulation17 Jul 2023

    Historical Redlining, Socioeconomic Distress, and Risk of Heart Failure Among Medicare Beneficiaries

    Cohort study

28. Eur J Heart Fail17 Jul 2023

    Heart Failure Diagnosis in the General Community – Who, how and When? A Clinical Consensus Statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

    Guideline or statement

29. Eur J Heart Fail17 Jul 2023

    Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Scientific Statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension

    Guideline or statement

30. Circulation13 Jul 2023

    Dual-Organ Transplantation: Indications, Evaluation, and Outcomes for Heart-Kidney and Heart-Liver Transplantation: A Scientific Statement From the American Heart Association

    Guideline or statement

31. Eur J Heart Fail13 Jul 2023

    Pre-Discharge and Early Post-Discharge Management of Patients Hospitalized for Acute Heart Failure: A Scientific Statement by the Heart Failure Association of the ESC

    Guideline or statement

32. J Am Coll Cardiol11 Jul 2023

    Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure

    Secondary analysis

33. Eur Heart J11 Jul 2023

    Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy

    Case-control study

34. Eur J Heart Fail11 Jul 2023

    The Cost-Effectiveness of Dapagliflozin in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: A European Health-Economic Analysis of the DELIVER Trial

    Randomised controlled trial

35. Eur J Prev Cardiol6 Jul 2023

    Prevalence of heart failure stages in the general population and implications for heart failure prevention: reports from the China Hypertension Survey 2012–15

    Cross-sectional study

36. Eur J Heart Fail5 Jul 2023

    Influenza Vaccination and Cardiovascular Events in Patients with Ischaemic Heart Disease and Heart Failure: A Meta-Analysis

    Meta-analysis

37. Circulation4 Jul 2023

    Inhaled Epoprostenol Compared With Nitric Oxide for Right Ventricular Support After Major Cardiac Surgery

    Randomised controlled trial

38. Europace1 Jul 2023

    Age-stratified comparison of prognosis in cardiac resynchronization therapy with or without prophylactic defibrillator for nonischemic cardiomyopathy—a nationwide cohort study

    Cohort study

39. JAMA Cardiol1 Jul 2023

    Association of Dapagliflozin vs Placebo With Individual Kansas City Cardiomyopathy Questionnaire Components in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the DELIVER Trial

    Secondary analysis

40. JAMA Cardiol1 Jul 2023

    Contemporary Use of Sodium-Glucose Cotransporter-2 Inhibitor Therapy Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the US: The Get With The Guidelines-Heart Failure Registry

    Cohort study

All 1,928 Briefs in ExploreShowing Briefs 1,761–1,800 of 1,928, newest first